Baseline characteristics of the patients in the low and high long chain triglyceride (LCT) groups (mean values)
| Low LCT (n=27) | High LCT (n=27) | p Value | |
| Age (y) | 36.9 | 35.6 | 0.71 |
| CDAI | 300 | 335 | 0.14 |
| VHAI | 175 | 188 | 0.25 |
| HBI | 8.9 | 11.2 | 0.032-150 |
| QOL score | 123 | 112 | 0.27 |
| Weight (kg) | 60.9 | 64.2 | 0.44 |
| BMI | 21.5 | 22.3 | 0.56 |
| Albumin (g/l) | 36 | 34 | 0.17 |
| Haemoglobin (g/dl) | 12.1 | 12.0 | 0.85 |
| CRP (mg/l) | 52.7 | 52.8 | 0.99 |
| ESR (mm/h) | 37.4 | 42.7 | 0.49 |
| WBC (×109/l) | 8.7 | 9.5 | 0.39 |
| Current smokers (n) | 8 | 8 | |
| Drug therapy (n) | |||
| 5-ASA | 11 | 10 | |
| Steroids | 6 | 4 | |
| Azathioprine | 4 | 4 | |
| Site of disease (n) | |||
| Ileal | 9 | 6 | |
| Ileocolonic | 12 | 12 | |
| Colonic | 6 | 9 |
CDAI, Crohn's disease activity index; HBI, Harvey Bradshaw index; VHAI, Van Hees activity index; QOL, quality of life; BMI, body mass index; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cells; 5-ASA, 5-aminosalicylic acid.
↵2-150 Significant difference.